Search Results - "RIECKMANN, Karl H"
-
1
First Assessment in Humans of the Safety, Tolerability, Pharmacokinetics, and Ex Vivo Pharmacodynamic Antimalarial Activity of the New Artemisinin Derivative Artemisone
Published in Antimicrobial Agents and Chemotherapy (01-09-2008)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
2
Evaluation of Artemisone Combinations in Aotus Monkeys Infected with Plasmodium falciparum
Published in Antimicrobial Agents and Chemotherapy (01-08-2009)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
3
Efficacy of Monthly Tafenoquine for Prophylaxis of Plasmodium vivax and Multidrug-Resistant P. falciparum Malaria
Published in The Journal of infectious diseases (15-10-2004)“…We assessed monthly doses of tafenoquine for preventing Plasmodium vivax and multidrug-resistant P. falciparum malaria. In a randomized, double-blind,…”
Get full text
Journal Article -
4
Simple In Vitro Assay for Determining the Sensitivity of Plasmodium vivax Isolates from Fresh Human Blood to Antimalarials in Areas where P. vivax Is Endemic
Published in Antimicrobial Agents and Chemotherapy (01-01-2003)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
5
Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea
Published in The American journal of tropical medicine and hygiene (01-08-1996)“…Plasmodium falciparum isolates from 24 Papua New Guinean patients with symptomatic malaria were tested for susceptibility to pyrimethamine and cycloguanil…”
Get more information
Journal Article -
6
Can primaquine therapy for vivax malaria be improved?
Published in Trends in parasitology (01-03-2003)“…The incidence and range of endemic malaria caused by Plasmodium vivax has expanded during the past 30 years. This parasite forms hypnozoites in the liver,…”
Get full text
Journal Article -
7
Does gender, food or grapefruit juice alter the pharmacokinetics of primaquine in healthy subjects?
Published in British journal of clinical pharmacology (01-06-2006)“…Aims To evaluate the effects of gender, food and grapefruit juice on the pharmacokinetics of primaquine in healthy subjects. Methods In a randomized, two‐phase…”
Get full text
Journal Article -
8
Phenoxypropoxybiguanides, Prodrugs of DHFR−Inhibiting Diaminotriazine Antimalarials
Published in Journal of medicinal chemistry (08-11-2001)“…A total of 34 analogues of the biguanide PS-15 (5s), a prodrug of the diaminotriazine WR-99210 (8s), have been prepared. Several of them, such as 5b (PS-33)…”
Get full text
Journal Article -
9
Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine
Published in Transactions of the Royal Society of Tropical Medicine and Hygiene (01-06-2007)“…The standard adult treatment regimen for Plasmodium vivax malaria is chloroquine (1500 mg over 3 d) plus primaquine (15 or 30 mg daily for 14 d), but patient…”
Get full text
Journal Article -
10
New haplotypes of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene among chloroquine-resistant parasite isolates
Published in The American journal of tropical medicine and hygiene (01-04-2003)“…Mutations in the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene were examined to assess their associations with chloroquine resistance…”
Get more information
Journal Article -
11
Antimalarial pharmacodynamics and pharmacokinetics of a third-generation antifolate—JPC2056—in cynomolgus monkeys using an in vivo–in vitro model
Published in Journal of antimicrobial chemotherapy (01-10-2007)“…Objectives To assess the antimalarial pharmacodynamics and pharmacokinetics of the novel dihydrofolate reductase (DHFR) inhibitor, JPC2056 and its principal…”
Get full text
Journal Article -
12
Short report: the activity of pamaquine, an 8-aminoquinoline drug, against sporozoite-induced infections of Plasmodium vivax (New Guinea strains)
Published in The American journal of tropical medicine and hygiene (01-08-2004)“…It was reported in 1946 that the administration of pamaquine during the incubation period delayed but did not prevent primary attacks of a New Guinea strain of…”
Get more information
Journal Article -
13
Plasma Concentrations of Tafenoquine, a New Long-Acting Antimalarial Agent, in Thai Soldiers Receiving Monthly Prophylaxis
Published in Clinical infectious diseases (15-12-2003)“…We measured plasma tafenoquine concentrations in Thai soldiers given a monthly regimen of tafenoquine to determine whether these concentrations adequately…”
Get full text
Journal Article -
14
Fatty food does not alter blood mefloquine concentrations in the treatment of falciparum malaria
Published in Transactions of the Royal Society of Tropical Medicine and Hygiene (01-12-2005)“…Food has been reported to increase the bioavailability of mefloquine in healthy volunteers, but its role in increasing blood mefloquine concentrations in…”
Get full text
Journal Article -
15
Cytotoxic Effects of Inhibitors of de Novo Pyrimidine Biosynthesis upon Plasmodium falciparum
Published in Biochemistry (Easton) (01-05-1994)“…The malarial parasite Plasmodium falciparum can only synthesize pyrimidine nucleotides via the de novo pathway which is therefore a suitable target for…”
Get full text
Journal Article -
16
WR 238605, chloroquine, and their combinations as blood schizonticides against a chloroquine-resistant strain of Plasmodium vivax in Aotus monkeys
Published in The American journal of tropical medicine and hygiene (01-05-1997)“…The compound WR 238605 is a primaquine analog being developed by the U.S. Army as an antimalarial drug. Currently, there is no established treatment for…”
Get more information
Journal Article -
17
Activity of PS-15 and its metabolite, WR99210, against Plasmodium falciparum in an in vivo-in vitro model
Published in Transactions of the Royal Society of Tropical Medicine and Hygiene (01-09-1996)“…An in vivo-in vitro model was used to assess the antimalarial activity of PS-15 and its metabolite, WR99210, against Plasmodium falciparum. WR99210, an…”
Get full text
Journal Article Conference Proceeding -
18
Risk factors of chloroquine resistance in Plasmodium falciparum malaria
Published in Acta tropica (01-08-1996)“…Objective: To identify patient-related risk factors of chloroquine resistance. Design: A case control study. Subjects: Plasmodium falciparum infected school…”
Get full text
Journal Article -
19
Chloroquine bioassay using malaria microcultures
Published in The American journal of tropical medicine and hygiene (01-10-1993)“…The in vitro microculture technique was used to develop a relatively simple bioassay for estimating chloroquine (CQ) in plasma or serum. Chloroquine…”
Get more information
Journal Article -
20
Plasma chloroquine concentrations in young and older malaria patients treated with chloroquine
Published in Acta tropica (10-09-1997)“…Plasma chloroquine (CQ) concentrations were measured by bioassay in young (0–4 years, n=9) and older (5–60 years, n=21) patients from Vanuatu infected with…”
Get full text
Journal Article